Scarica l'app Stockscreener
9.185
0.15%
0.025
Precedente Chiudi:
$9.16
Aprire:
$9.28
Volume 24 ore:
133.33K
Relative Volume:
0.02
Capitalizzazione di mercato:
$2.13B
Reddito:
$509.86M
Utile/perdita netta:
$165.35M
Rapporto P/E:
13.55
EPS:
0.6779
Flusso di cassa netto:
$107.55M
1 W Prestazione:
+9.61%
1M Prestazione:
+15.11%
6M Prestazione:
-51.25%
1 anno Prestazione:
-48.69%
Intervallo 1D:
$9.15
$9.31
Intervallo di 1 settimana:
$8.52
$9.31
Portata 52W:
$7.2101
$20.46
Adma Biologics Inc Stock (ADMA) Company Profile
Nome
Adma Biologics Inc
Settore
Industria
Telefono
(201) 478-5552
Indirizzo
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
9.175 | 1.94B | 509.86M | 165.35M | 107.55M | 0.6779 |
VRTX
Vertex Pharmaceuticals Inc
|
519.88 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
661.27 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
927.55 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
316.88 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
187.82 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-21 | Iniziato | Canaccord Genuity | Buy |
| 2026-03-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2023-07-19 | Ripresa | Raymond James | Strong Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2021-11-11 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Iniziato | Jefferies | Buy |
| 2019-04-15 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-07 | Ripresa | H.C. Wainwright | Buy |
| 2017-12-11 | Reiterato | Maxim Group | Buy |
| 2017-11-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Aggiornamento | Maxim Group | Hold → Buy |
| 2016-08-01 | Downgrade | Maxim Group | Buy → Hold |
| 2016-07-25 | Reiterato | Maxim Group | Buy |
| 2015-05-13 | Reiterato | Maxim Group | Buy |
| 2014-12-08 | Iniziato | Oppenheimer | Outperform |
| 2014-12-01 | Reiterato | Maxim Group | Buy |
Mostra tutto
Adma Biologics Inc Borsa (ADMA) Ultime notizie
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NNOX - GlobeNewswire Inc.
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
ADMA Biologics, Inc. Class Action Lawsuit Seeks Recovery - GlobeNewswire
ADMA DEADLINE: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. Investors of Upcoming Securities Class Action Deadline - PR Newswire
ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL - GlobeNewswire
ADMA Stock Downgraded By Cantor As ‘Channel Stuffing’ Claims Shake Investor Confidence - Stocktwits
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - GlobeNewswire Inc.
ADMA Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026 - marketscreener.com
ADMA Tumbles On Slashed Outlook As Short-Seller Aftermath Meets Competitive Headwinds - Stocktwits
Trading Systems Reacting to (ADMA) Volatility - Stock Traders Daily
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
ADMA Biologics (NASDAQ: ADMA) Investigated for Potential - GlobeNewswire
ADMA Biologics, Inc. (ADMA) Investigation: Bronstein, Gewirtz & G - The National Law Review
$ADMA Notification: ADMA Biologics Accused of Misrepresentations about its Revenue Sources in Securities Fraud Class Action - TradingView
Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo! Finance Canada
ADMA BIOLOGICS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates ADMA Biologics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ADMA - Business Wire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the FirmADMA - TMX Newsfile
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Investor Announcement: ADMA Biologics Investors are Notified to Contact BFA Law about the Pending Securities Fraud Class Action to Recover Stock Losses - GlobeNewswire
ADMA Biologics, Inc.(NasdaqGM: ADMA) added to Russell 2000 Growth-Defensive Index - marketscreener.com
ADMA Biologics, Inc. (ADMA) Class Action Lawsuit Seeks Recovery for Investors; August 10, 2026, DeadlineContact Kessler Topaz Meltzer & Check, LLP - NewMediaWire
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ADMA Biologics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ADMA Biologics Faces Securities Fraud Class Action Lawsuit - Intellectia AI
ADMA Biologics, Inc. Actuals & Estimates (NASDAQ:ADMA) - TradingView
Kessler Topaz Meltzer & Check, LLP - GlobeNewswire Inc.
Did You Lose Money on ADMA Biologics, Inc. (ADMA)? Levi & Korsinsky Urges Investors to Act Before August 10, 2026 - ACCESS Newswire
Levi & Korsinsky Urges ADMA Biologics, Inc. (ADMA) Shareholders to Act Before Lead Plaintiff Deadline August 10, 2026 - ACCESS Newswire
ADMA Biologics, Inc. Actuals & Estimates (BX:ADMA) - TradingView
Levi & Korsinsky Notifies ADMA Biologics, Inc. (ADMA) Shareholders of Class Action Lawsuit and August 10, 2026 Deadline - ACCESS Newswire
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc.ADMA - PR Newswire
ADMA SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of ADMA Biologics, Inc. Investors - GlobeNewswire Inc.
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - The Keene Sentinel
Class Action Lawsuit Filed Against ADMA Biologics, Inc. (ADMA)Recover LossesContact Levi & Korsinsky Before August 10, 2026 - ACCESS Newswire
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ADMA Biologics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders - GlobeNewswire
DEADLINE ALERT for VIA, Z, and ADMA: The Law Offices of - GlobeNewswire
ADMA Shareholder Alert: ADMA Biologics, Inc. Securities - GlobeNewswire
ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Deadline in Securities Fraud Class Action Lawsuit - The Globe and Mail
ADMA Biologics Inc (ADMA) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
ADMA Biologics, Inc. Actuals & Estimates (BOATS:ADMA) - TradingView
Price to earnings forward of ADMA Biologics Inc – NASDAQ:ADMA - TradingView
Enterprise value to revenue forward of ADMA Biologics Inc – NASDAQ:ADMA - TradingView
What Are the Allegations Against ADMA Biologics - Kavout | AI
ADMA LAWSUIT ALERT: Levi & Korsinsky Notifies ADMA Biologics, Inc. InvestorsLead Plaintiff Deadline August 10, 2026 - ACCESS Newswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The FirmADMA - ACCESS Newswire
Contact Levi & Korsinsky by August 10, 2026 to Join Class Action Against ADMA Biologics, Inc. (ADMA) - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds ADMA Biologics, Inc. (ADMA) Investors of August 10, 2026 Deadline - ACCESS Newswire
Enterprise value to EBITDA forward of ADMA Biologics Inc – NASDAQ:ADMA - TradingView
Lost Money on ADMA Biologics, Inc. (ADMA)? Contact Levi & Korsinsky Before August 10, 2026 to Join Class Action - ACCESS Newswire
ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel ... - Caledonian Record
Adma Biologics Inc Azioni (ADMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Adma Biologics Inc Azioni (ADMA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Grossman Jerrold B | Director |
May 12 '26 |
Buy |
8.01 |
12,500 |
100,125 |
513,884 |
| Grossman Jerrold B | Director |
May 11 '26 |
Buy |
8.01 |
12,500 |
100,125 |
501,384 |
| Guiheen Lawrence P. | Director |
Mar 13 '26 |
Option Exercise |
3.66 |
30,000 |
109,800 |
135,520 |
| Grossman Adam S | President and CEO |
Mar 16 '26 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,133,777 |
| Grossman Adam S | President and CEO |
Mar 16 '26 |
Sale |
15.16 |
21,000 |
318,360 |
2,112,777 |
1.95%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):